{"eventGroups":[{"description":"The dose of sunitinib malate will be a continuous daily dose of 37.5 mg administered orally for 6 weeks. The cycle of therapy is 42 days (or 6 weeks)\n\nsunitinib malate","id":"EG000","otherNumAffected":8,"otherNumAtRisk":10,"seriousNumAffected":1,"seriousNumAtRisk":10,"title":"Sunitinib Malate"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":10,"numEvents":2}],"term":"ALT, SGPT"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Glucose, high (hyperglycemia)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Hemorrhage, Nose"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":10,"numEvents":4}],"term":"Leukocytes (total WBC)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":10,"numEvents":2}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":10,"numEvents":2}],"term":"Mucositis (func/sympt)- Oral cavity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Neuropathy: motor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Neuropathy: sensory"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Pain - Extremity-limb"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Rash/desquamation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Urinary frequency/urgency"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTC-3.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":10,"numEvents":1}],"term":"Hemorrhage, Abdomen NOS"}]}